Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TARBP1 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | EFEMP2 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
mRNA | CYP3A7 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | ERV3-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | MAGED1 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
mRNA | FBRSL1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | NEK1 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | SGCE | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
mRNA | ANTXRL | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | CELF2 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |